References
- Swale DR, Kharade SV, Denton JS. Cardiac and renal inward rectifier potassium channel pharmacology: emerging tools for integrative physiology and therapeutics. Curr Opin Pharmacol. 2014;15:7-15. doi:10.1016/j.coph.2013.11.002. PMID:24721648
- Lewis LM, Bhave G, Chauder BA, Banerjee S, Lornsen KA, Redha R, Fallen K, Lindsley CW, Weaver CD, Denton JS., High-throughput screening reveals a small-molecule inhibitor of the renal outer medullary potassium channel and Kir7.1. Mol Pharmacol. 2009;76(5):1094-103. doi:10.1124/mol.109.059840. PMID:19706730
- Denton JS, Pao AC, Maduke M. Novel Diuretic Targets. Am J Physiol Renal Physiol. 2013;305(7):F931-42. doi:10.1152/ajprenal.00230.2013. PMID:23863472
- McCloskey C, Rada C, Bailey E, McCavera S, van den Berg HA, Atia J, Rand DA, Shmygol A, Chan YW, Quenby S, et al. The inwardly rectifying K+ channel KIR7.1 controls uterine excitability throughout pregnancy. EMBO Mol Med. 2014;6(9):1161-74. doi:10.15252/emmm.201403944. PMID:25056913
- Ghamari-Langroudi M, Digby GJ, Sebag JA, Millhauser GL, Palomino R, Matthews R, Gillyard T, Panaro BL, Tough IR, Cox HM, et al. G-protein-independent coupling of MC4R to Kir7.1 in hypothalamic neurons. Nature. 2015;520(7545):94-8. doi:10.1038/nature14051. PMID:25600267
- Kharade S, Sheehan J, Figueroa E, Meiler J, Denton J. Pore polarity and charge determine differential block of Kir1.1 and Kir7.1 potassium channels by the small-molecule inhibitor VU590. Mol Pharmacol. 2017;92(3):338-346. doi:10.1124/mol.117.108472. PMID:28619748
- Swale DR, Kurata H, Kharade SV, Sheehan J, Raphemot R, Voigtritter KR, Figueroa EE, Meiler J, Blobaum AL, Lindsley CW, Hopkins CR, Denton JS. ML418: The first selective, sub-micromolar pore blocker of Kir7.1 potassium channels. ACS Chem Neurosci. 2016;7(7):1013-23. doi:10.1021/acschemneuro.6b00111. PMID:27184474